BSE MidCap BSE SmallCap

FIIs have offloaded Indian equities worth a total of Rs 98,086 crore on the stock exchanges till October 24, data from NSDL showed

Midcap Index, SmallCap index: The mid- and small-cap indices on the NSE back home have gained 25.7 per cent and 26.7 per cent, respectively in CY24

PC Jeweller, MTNL, Kitex Garments, 63 Moons Tech, Genus Power, Refex Industries, Solara Active Pharma, and Suraj Estates Developers were locked in 5 per cent lower circuit on the BSE.

Borosil Renewables has recently experienced a significant price decline after reaching its peak near Rs 573, losing around 87 points, which translates to a 15 per cent drop.

Midcap, smallcap stocks: The market rally in the past few months, including the mid-and small-cap segments, analysts believe, has been on the back of strong inflow from the DIIs

The rise in the share price came after the company announced that it has successfully commissioned a new Hydrogen Peroxide plant.

The cost of the project is Rs 899 crore, the company said in a statement.

The retail chain operator faces several hurdles, including evolving customer preferences, disruptions in transport logistics, and intensifying competition, analysts at domestic brokerage Nuvama said.

The share price rose after the company reported a strong set of numbers in the June quarter of financial year 2025 (Q1FY25).

The fall in the share price came on the back of weak June quarter of financial year 2025 (Q1FY25) results.

Tata Power stock price has broken out on the daily chart to close at all time high with sharp rise in volumes.

The Nifty Energy Index also exhibits a bullish trend on the charts in the near term. However, maintaining a strict stop-loss is essential for all bullish positions.

The share price jumped after the company announced that it has secured an order with Rs 160 crore from Suruchi Properties, a group company of Century Real Estate Holdings.

The shares surged after the pharmaceutical major announced that it has secured final nod from United States Food and Drug Administration (USFDA) for Valsartan tablets.

The fall in the stock price came after the company announced a weak set of June quarter results (Q1FY25).

True to this pattern, Tata Consumer has recently shown a decisive breakout, marked by substantial trading volume.

The Nifty-50 is expected to deliver 12% earnings growth in FY25 over a high base of FY24 (+26 per cent Y-o-Y), said Khemka.

The rally in microcap stocks, according to Devarsh Vakil, Deputy Head of Retail Research, HDFC Securities, has been on the back of growth in earnings in a lot of these companies

The uptick in stock price came after the company announced that it has secured a 'significant' order from JNK Global.

The NSE Nifty50 fell 1.19 per cent or 291 points, reaching a low of 24,141.80 levels